Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

6/30/2020 API Import to Russia (May 2020)

Between January and May 2020, Russia imported 69.7 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 51% higher than in 2019. The dynamics in physical terms (kilograms) are +21%, with the import volume of 5.8 thousand tons.

6/29/2020 Pharmaceutical Drug Import to Russia (May 2020)

Between January and May 2020, Russia imported 168.6 bln RUB worth of ready-made pharmaceuticals (customs clearance and VAT included), which is in monetary terms (rubles) 27% lower than in 2019, and 52.5 bln RUB worth of in-bulk drugs, which is 12% higher than in 2019.

6/25/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (May 2020)

Between January and May 2020, the sales of veterinary drugs in the retail market amounted to 8.9 bln RUB (retail prices, VAT included). While the dynamics in monetary terms (rubles) are only +0.9%, sales got back to normal in May after April’s devastating results (the dynamics for the period between January and April were +0.6%). If calculated in minimum dosage units (MDU), the market volume is 82.4 mln MDUs, with the dynamics of +3.4%.

6/24/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Russian Doctors Do not Think that the COVID-19 Epidemic in Russia Has Ended Yet

53% of doctors believe that the coronavirus epidemic in Russia has not yet ended, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. That is why it is too early to make predictions about the beginning of the so-called “second wave” of the disease. Here, we can also see some serious gender differences; 59% of the female and only in 35% the male respondents do not think the epidemic has ended.

6/23/2020 Pharmaceutical Drug Production in Russia (May 2020)

Between January and May 2020, Russia manufactured 189.1 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 20% higher than in 2019. The dynamics in physical terms (units) are +8.2% (1.88 bln units). If calculated in minimum dosage units (MDU), the dynamics are +11.7% (33.2 bln MDUs).

6/18/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 76% of Russian Doctors Do not Find Mass COVID Vaccination Necessary

Only 19% of doctors advocate mass vaccination of the population against COVID-19 and consider it necessary to introduce the vaccine into the National Preventive Vaccination Calendar, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

6/17/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): at least 35% of Doctors in Contact with COVID Patients will not Receive Incentive Payments due to Formal Reasons

1,579 respondents from more than 200 cities and towns in Russia took part in an online survey conducted from May 26 to June 9, 2020 by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

6/5/2020 Import of Veterinary Drugs and Feed Supplements to Russia (April 2020)

Between January and April 2020, Russia imported 8.4 bln RUB worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 9% lower than in 2019. The dynamics of the import of feed supplements in monetary terms are +12%, with 13.4 bln RUB.

6/4/2020 API Import to Russia (April 2020)

Between January and April 2020, Russia imported 56.7 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 60% higher than in 2019. While the average price per 1 kg has increased by nearly 30% (to 12.8 thousand RUB, customs clearance and VAT included), the dynamics in physical terms (kg) are +23%, with the import amounting to 4.4 thousand tons.

6/3/2020 Pharmaceutical Drug Import to Russia (April 2020)

Between January and April 2020, Russia imported 108.8 bln RUB worth of ready-made pharmaceutical drugs (customs clearance and VAT included), which is in monetary terms (rubles) 39% lower than in 2019. The in-bulk import amounted to 44.1 bln RUB, with the dynamics of +9%.